Report Detail

Pharma & Healthcare Global Transdermal Skin Patch Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3358311
  • |
  • 29 April, 2019
  • |
  • Global
  • |
  • 120 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Scope of the Report:
The worldwide market for Transdermal Skin Patch is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Transdermal Skin Patch in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch

Market Segment by Applications, can be divided into
Relieve Severe Pain
Stop Smoking Cigarettes
Treat An Overactive Bladder
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Skin Patch product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Skin Patch, with price, sales, revenue and global market share of Transdermal Skin Patch in 2017 and 2018.
Chapter 3, the Transdermal Skin Patch competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Skin Patch breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Transdermal Skin Patch market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Transdermal Skin Patch sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Transdermal Skin Patch Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Fentanyl Transdermal Skin Patch
      • 1.2.2 Nicotine Transdermal Skin Patch
      • 1.2.3 Clonidine Transdermal Skin Patch
      • 1.2.4 Buprenorphine Transdermal Skin Patch
    • 1.3 Market Analysis by Applications
      • 1.3.1 Relieve Severe Pain
      • 1.3.2 Stop Smoking Cigarettes
      • 1.3.3 Treat An Overactive Bladder
      • 1.3.4 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Hisamitsu Pharmaceutical
      • 2.1.1 Business Overview
      • 2.1.2 Transdermal Skin Patch Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Novartis
      • 2.2.1 Business Overview
      • 2.2.2 Transdermal Skin Patch Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Novartis Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Johnson & Johnson
      • 2.3.1 Business Overview
      • 2.3.2 Transdermal Skin Patch Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Teikoku Pharma
      • 2.4.1 Business Overview
      • 2.4.2 Transdermal Skin Patch Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Mylan
      • 2.5.1 Business Overview
      • 2.5.2 Transdermal Skin Patch Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Mylan Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Actavis
      • 2.6.1 Business Overview
      • 2.6.2 Transdermal Skin Patch Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Actavis Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Mundipharma
      • 2.7.1 Business Overview
      • 2.7.2 Transdermal Skin Patch Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Mundipharma Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Henan Lingrui Pharmaceutical
      • 2.8.1 Business Overview
      • 2.8.2 Transdermal Skin Patch Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Changzhou Siyao
      • 2.9.1 Business Overview
      • 2.9.2 Transdermal Skin Patch Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Rfl Pharmaceutical
      • 2.10.1 Business Overview
      • 2.10.2 Transdermal Skin Patch Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Luye Pharma Group Ltd.
      • 2.11.1 Business Overview
      • 2.11.2 Transdermal Skin Patch Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Purdue Pharma L.P.
      • 2.12.1 Business Overview
      • 2.12.2 Transdermal Skin Patch Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Teva Pharmaceutical Industries Ltd.
      • 2.13.1 Business Overview
      • 2.13.2 Transdermal Skin Patch Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Transdermal Skin Patch Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Transdermal Skin Patch Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Transdermal Skin Patch Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Transdermal Skin Patch Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Transdermal Skin Patch Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Transdermal Skin Patch Market Analysis by Regions

    • 4.1 Global Transdermal Skin Patch Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Transdermal Skin Patch Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Transdermal Skin Patch Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 4.3 Europe Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 4.5 South America Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Transdermal Skin Patch Sales and Growth Rate (2014-2019)

    5 North America Transdermal Skin Patch by Country

    • 5.1 North America Transdermal Skin Patch Sales, Revenue and Market Share by Country
      • 5.1.1 North America Transdermal Skin Patch Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Transdermal Skin Patch Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 5.3 Canada Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Transdermal Skin Patch Sales and Growth Rate (2014-2019)

    6 Europe Transdermal Skin Patch by Country

    • 6.1 Europe Transdermal Skin Patch Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Transdermal Skin Patch Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Transdermal Skin Patch Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 6.3 UK Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 6.4 France Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 6.5 Russia Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 6.6 Italy Transdermal Skin Patch Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Transdermal Skin Patch by Country

    • 7.1 Asia-Pacific Transdermal Skin Patch Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Transdermal Skin Patch Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Transdermal Skin Patch Revenue and Market Share by Country (2014-2019)
    • 7.2 China Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 7.3 Japan Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 7.4 Korea Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 7.5 India Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Transdermal Skin Patch Sales and Growth Rate (2014-2019)

    8 South America Transdermal Skin Patch by Country

    • 8.1 South America Transdermal Skin Patch Sales, Revenue and Market Share by Country
      • 8.1.1 South America Transdermal Skin Patch Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Transdermal Skin Patch Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Transdermal Skin Patch Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Transdermal Skin Patch by Countries

    • 9.1 Middle East and Africa Transdermal Skin Patch Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Transdermal Skin Patch Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Transdermal Skin Patch Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Transdermal Skin Patch Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Transdermal Skin Patch Sales and Growth Rate (2014-2019)

    10 Global Transdermal Skin Patch Market Segment by Type

    • 10.1 Global Transdermal Skin Patch Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Transdermal Skin Patch Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Transdermal Skin Patch Revenue and Market Share by Type (2014-2019)
    • 10.2 Fentanyl Transdermal Skin Patch Sales Growth and Price
      • 10.2.1 Global Fentanyl Transdermal Skin Patch Sales Growth (2014-2019)
      • 10.2.2 Global Fentanyl Transdermal Skin Patch Price (2014-2019)
    • 10.3 Nicotine Transdermal Skin Patch Sales Growth and Price
      • 10.3.1 Global Nicotine Transdermal Skin Patch Sales Growth (2014-2019)
      • 10.3.2 Global Nicotine Transdermal Skin Patch Price (2014-2019)
    • 10.4 Clonidine Transdermal Skin Patch Sales Growth and Price
      • 10.4.1 Global Clonidine Transdermal Skin Patch Sales Growth (2014-2019)
      • 10.4.2 Global Clonidine Transdermal Skin Patch Price (2014-2019)
    • 10.5 Buprenorphine Transdermal Skin Patch Sales Growth and Price
      • 10.5.1 Global Buprenorphine Transdermal Skin Patch Sales Growth (2014-2019)
      • 10.5.2 Global Buprenorphine Transdermal Skin Patch Price (2014-2019)

    11 Global Transdermal Skin Patch Market Segment by Application

    • 11.1 Global Transdermal Skin Patch Sales Market Share by Application (2014-2019)
    • 11.2 Relieve Severe Pain Sales Growth (2014-2019)
    • 11.3 Stop Smoking Cigarettes Sales Growth (2014-2019)
    • 11.4 Treat An Overactive Bladder Sales Growth (2014-2019)
    • 11.5 Others Sales Growth (2014-2019)

    12 Transdermal Skin Patch Market Forecast (2019-2024)

    • 12.1 Global Transdermal Skin Patch Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Transdermal Skin Patch Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Transdermal Skin Patch Market Forecast (2019-2024)
      • 12.2.2 Europe Transdermal Skin Patch Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Transdermal Skin Patch Market Forecast (2019-2024)
      • 12.2.4 South America Transdermal Skin Patch Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Transdermal Skin Patch Market Forecast (2019-2024)
    • 12.3 Transdermal Skin Patch Market Forecast by Type (2019-2024)
      • 12.3.1 Global Transdermal Skin Patch Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Transdermal Skin Patch Market Share Forecast by Type (2019-2024)
    • 12.4 Transdermal Skin Patch Market Forecast by Application (2019-2024)
      • 12.4.1 Global Transdermal Skin Patch Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Transdermal Skin Patch Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Transdermal Skin Patch. Industry analysis & Market Report on Transdermal Skin Patch is a syndicated market report, published as Global Transdermal Skin Patch Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Transdermal Skin Patch market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,780.52
      4,170.78
      5,561.04
      3,246.84
      4,870.26
      6,493.68
      541,314.00
      811,971.00
      1,082,628.00
      289,988.40
      434,982.60
      579,976.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report